Thermo Fisher Nears $10B All-Cash Deal to Acquire Clinical Trial Data Leader Clario

According to Reuters, citing the Financial Times10Month28Reported on the day, Thermo Fisher Scientific (Thermo Fisher, Stock CodeTMO.N) is nearing an all-cash acquisition of U.S. clinical trial data management companyClario, this deal is forClariois valued at approximately100Billion US dollars.

If the deal is ultimately reached, it will be its first...2021Year174Billion-dollar acquisitionCRO PPDThe largest acquisition by Thermo Fisher Scientific in over a century.

Thermo Fisher Scientific andClarioNeither party has made an immediate response to the request for comment.

ClarioFounded in2021Year, by Thermo Fisher Scientific Inc.ERTAndBioclinicaMerged to form, with the core business of providing clinical trial-related software services to pharmaceutical companies.

Its shareholders includeNordic CapitalAndAstorgSuch well-known private equity groups have deep accumulation in fields like clinical data management and trial operation support.

Notably, Thermo Fisher Scientific has been highly active in the mergers and acquisitions arena. Earlier this year, Thermo Fisher announced that it would...41Billion-dollar Acquisition of Medical Device ManufacturerSolventumPurification and Filtration Business.

Thanks to the robust demand in the laboratory tools market and the synergies from recent acquisitions, Thermo Fisher Scientific Inc. raised its annual profit and revenue forecast last week. This proposed acquisitionClario, which will further improve its layout in the pharmaceutical R&D industry chain and strengthen its competitiveness in the field of clinical data management.

●Heavyweight! Novartis Sells Two Key Ophthalmology Products

●WuXi AppTec Sells Two Subsidiaries for 2.8 Billion Yuan, Gaoling Takes Over!

●Breakthrough Progress! Cell Therapy Product for Multiple System Atrophy Approved for Full-Cycle Clinical Trials